Publisher: Advanstar Communications, Inc.   (Total: 6 journals)   [Sort alphabetically]

Showing 1 - 7 of 7 Journals sorted by number of followers
Biopharm Intl.     Full-text available via subscription   (Followers: 20, SJR: 0.172, CiteScore: 0)
Applied Clinical Trials     Full-text available via subscription   (Followers: 7)
Pharmaceutical Technology     Full-text available via subscription   (Followers: 6, SJR: 0.127, CiteScore: 0)
Pharmaceutical Executive     Full-text available via subscription   (Followers: 6)
Contemporary OB GYN     Full-text available via subscription   (Followers: 4, SJR: 0.106, CiteScore: 0)
Contemporary Pediatrics     Full-text available via subscription   (Followers: 3)
Dermatology Times     Free  
Similar Journals
Journal Cover
Pharmaceutical Technology
Journal Prestige (SJR): 0.127
Number of Followers: 6  
 
  Full-text available via subscription Subscription journal
ISSN (Online) 1753-2715
Published by Advanstar Communications, Inc. Homepage  [6 journals]
  • AstraZeneca and RQ Biotechnology Sign License Agreement for Monoclonal
           Antibodies

    • Free pre-print version: Loading...

      Abstract: AstraZeneca has signed a license agreement with RQ Biotechnology for monoclonal antibodies to treat COVID-19.
      PubDate: Mon, 23 May 2022 20:09:00 +000
       
  • PTC Therapeutics Receives Positive Opinion for Upstaza

    • Free pre-print version: Loading...

      Abstract: PTC Therapeutics has received a positive opinion from EMA for Upstaza for the treatment of AADC deficiency.
      PubDate: Mon, 23 May 2022 20:07:00 +000
       
  • FDA Issues Labeling Guidance

    • Free pre-print version: Loading...

      Abstract: The final guidance addresses safety aspects of container and carton labeling design.
      PubDate: Mon, 23 May 2022 19:59:00 +000
       
  • The Urgency for GxP Digital Transformation Projects in Biotech and Pharma

    • Free pre-print version: Loading...

      PubDate: Mon, 23 May 2022 15:30:00 +000
       
  • Modern Alternatives to Enzymatic Capping of mRNA

    • Free pre-print version: Loading...

      Abstract: For companies looking to bring mRNA therapeutics and vaccines to market, TriLink’s proprietary GMP-grade CleanCap® reagents offer an immediate solution for swiftly scaling from clinical to commercial. CleanCap technology is the fastest and easiest way to produce a 5’ Cap1 mRNA with 95% efficiency. GMP CleanCap reagents are a modern alternative to enzymatic capping and are ready to accelerate your mRNA therapeutic development. In this podcast, we will discuss how TriLink discovered this mRNA capping method and how they made it scalable to support global vaccine supply, as a key raw material for over 3 billion vaccines doses against COVID-19.
      PubDate: Mon, 23 May 2022 04:00:23 +000
       
  • A New Way to Cap mRNAs While the mRNA is Made

    • Free pre-print version: Loading...

      PubDate: Mon, 23 May 2022 04:00:00 +000
       
  • FDA Stresses Risk Management Plans

    • Free pre-print version: Loading...

      Abstract: The agency is asking drug manufacturers to ensure a strong supply chain by developing risk management plans.
      PubDate: Fri, 20 May 2022 20:29:00 +000
       
  • How COVID-19 Transformed Cleaning in Critical Environments

    • Free pre-print version: Loading...

      Abstract: This white paper will highlight critical cleaning standards trending in controlled environments and profile the top cleaning products for COVID-19 and beyond.
      PubDate: Fri, 20 May 2022 15:30:00 +000
       
  • Our inVia™ Qontor® Raman microscope

    • Free pre-print version: Loading...

      Abstract: The inVia™ Qontor® microscope's optical tweezing performance depends on the optical properties of the particles and the medium. Typically, it can trap particles smaller than 10 'm.
      PubDate: Fri, 20 May 2022 15:30:00 +000
       
  • Catalent Invests $175 Million to Expand Manufacturing Capabilities and
           Capacity in US Facility

    • Free pre-print version: Loading...

      Abstract: Catalent has announced a $175 million project to expand its manufacturing facility for large scale oral dose forms at its Winchester, Ky, site.
      PubDate: Fri, 20 May 2022 13:16:29 +000
       
  • FDA Approves Lilly’s Novel, Dual-Targeted Treatment for Type 2
           Diabetes

    • Free pre-print version: Loading...

      Abstract: FDA has approved Mounjaro (tirzepatide) injections as a treatment to improve blood sugar control in adults with type 2 diabetes.
      PubDate: Fri, 20 May 2022 13:09:28 +000
       
  • Trends in Manufacturing

    • Free pre-print version: Loading...

      PubDate: Fri, 20 May 2022 04:00:00 +000
       
  • Laying the Foundation for Smart Manufacturing While Solving Today’s
           Tough Challenges

    • Free pre-print version: Loading...

      PubDate: Fri, 20 May 2022 04:00:00 +000
       
  • Achieve Unparalleled Batch Control and Business Agility in an Increasingly
           Competitive Pharma Industry

    • Free pre-print version: Loading...

      PubDate: Thu, 19 May 2022 15:30:00 +000
       
  • White Paper: AI Algorithm Qualification for Pharma Manufacturing

    • Free pre-print version: Loading...

      Abstract: This paper explores a Quality by Design (QbD) approach to applying Artificial Intelligence (AI) in pharma manufacturing, and demonstrates how to leverage third party platforms to qualify AI algorithms for pharmaceutical product and medical device productivity chains.
      PubDate: Thu, 19 May 2022 04:00:00 +000
       
  • The Road to Continued Process Verification (CPV) v2

    • Free pre-print version: Loading...

      Abstract: CPV will soon become a necessity in pharmaceutical manufacturing, if companies wish to retain a competitive advantage. This paper explores how to embed it into existing production processes to optimize the increasingly pervasive continuous manufacturing ecosystem of today
      PubDate: Thu, 19 May 2022 04:00:00 +000
       
  • Pfizer and BioNTech Granted EUA for Booster Dose of COVID-19 Vaccine in
           Young Children

    • Free pre-print version: Loading...

      Abstract: Pfizer and BioNTech’s COVID-19 vaccine has been granted EUA for booster doses in children five through 11 years of age.
      PubDate: Wed, 18 May 2022 19:17:00 +000
       
  • Pfizer and BioNTech Update COVID-19 Vaccine Supply Agreement with EC

    • Free pre-print version: Loading...

      Abstract: The companies have reached an agreement with the European Commission to update their COVID-19 vaccine supply agreement.
      PubDate: Wed, 18 May 2022 19:13:00 +000
       
  • The Ever-Changing World of Extractables and Leachables, Part 4, A Free
           Virtual Conference

    • Free pre-print version: Loading...

      Abstract: Wednesday, May 18th, 2022 at 3pm BST 10am EDT 4pm CEST 7am PDTJoin global industry and regulatory experts as they discuss current E&L hot topics on pharmaceuticals, biopharmaceuticals and medical devices.
      PubDate: Wed, 18 May 2022 15:15:00 +000
       
  • Drug Solutions Podcast: FDA Weighs in on Advancing the Science of
           Pharmaceutical Manufacturing

    • Free pre-print version: Loading...

      Abstract: In this episode of the Drug Solutions Podcast, Chris Spivey, editorial director, interviews Michael Kopcha, Sau Lee, and Cindy Buhse of FDA about not being afraid to try new approaches and how they invite fresh ideas and abundant communication.
      PubDate: Tue, 17 May 2022 12:00:00 +000
       
  • Technical Review of Twin Screw Extrusion Technologies for Life Science
           Applications v13

    • Free pre-print version: Loading...

      PubDate: Tue, 17 May 2022 04:00:00 +000
       
  • Avacta Establishes New Therapeutics Headquarters

    • Free pre-print version: Loading...

      Abstract: Avacta is relocating its therapeutics headquarters to Scale Space in Imperial College’s White City Campus, London, United Kingdom.
      PubDate: Mon, 16 May 2022 18:49:31 +000
       
  • Pfizer to Acquire Biohaven Pharmaceuticals for $11.7 Billion

    • Free pre-print version: Loading...

      Abstract: Pfizer will acquire Biohaven Pharmaceuticals, a clinical-stage biopharmaceutical company specializing in migraine treatments, for $11.7 billion.
      PubDate: Mon, 16 May 2022 18:44:40 +000
       
  • Supply-Chain Challenges and Innovations in Pharma Packaging

    • Free pre-print version: Loading...

      Abstract: Innovations address sustainability, serialization, and supply-chain issues.
      PubDate: Mon, 16 May 2022 13:30:00 +000
       
  • Automated LC-MS method development 

    • Free pre-print version: Loading...

      Abstract: This application note demonstrates a streamlined HPLC method scouting workflow for the analysis of esomeprazole and related degradation products.
      PubDate: Mon, 16 May 2022 04:00:00 +000
       
  • Demonstrating a Fully Continuous Bioprocess

    • Free pre-print version: Loading...

      Abstract: Flexible and efficient methods are needed for biopharmaceutical manufacturing.
      PubDate: Mon, 16 May 2022 03:45:00 +000
       
  • Manufacturing OSD Forms: Key Trends Shaping the Industry

    • Free pre-print version: Loading...

      Abstract: The latest manufacturing technologies are essential for helping pharmaceutical formulators meet up-and-coming trends in OSD treatments.
      PubDate: Mon, 16 May 2022 03:00:00 +000
       
  • Don’t Gamble on Tablet Tooling Maintenance

    • Free pre-print version: Loading...

      Abstract: By following some fundamental steps, manufacturers can optimize their tablet tooling maintenance and resulting productivity.
      PubDate: Mon, 16 May 2022 01:30:00 +000
       
  • Implementing Continuous Bioprocessing: From Theory to Practice

    • Free pre-print version: Loading...

      Abstract: The struggle to implement continuous biomanufacturing at GMP level is slowly advancing.
      PubDate: Mon, 16 May 2022 00:00:00 +000
       
  • The Lighthouse Effect: Using Technology to Improve Life Sciences
           Manufacturing

    • Free pre-print version: Loading...

      Abstract: Lighthouse manufacturing techniques utilize technology and automation tostreamline production.
      PubDate: Sun, 15 May 2022 19:41:00 +000
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 34.231.247.88
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-